IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
A Review of Therapies for Primary Biliary Cholangitis
Abstract: Primary biliary cholangitis (PBC) is a rare, chronic, progressive autoimmune cholestatic liver disease that can lead to cirrhosis if left untreated. Ursodeoxycholic acid remains the […]
From Recent Issues
Feature
Impact of Menopause and Clinical Considerations in Patients With Inflammatory Bowel Disease
Abstract: Menopause is marked by a natural decline in estrogen and progesterone that alters gut barrier integrity, immune regulation, and systemic inflammation. In women with inflammatory […]
Feature
Beyond Medication: Integrative and Nutrition Therapies for Disorders of Gut-Brain Interaction
Abstract: Disorders of gut-brain interaction (DGBIs), such as irritable bowel syndrome and functional dyspepsia, affect a substantial portion of the global population. These disorders are best […]
Feature
Recent Advances in the Epidemiology, Screening, and Management of Hepatitis C Virus Infection in Pregnancy
Abstract: Hepatitis C virus (HCV) affects an estimated 58 million people worldwide, with rising rates among women of reproductive age. This trend has important implications in […]
Supplements
Highlights in MASH From the AASLD 2025 Liver Meeting
A Review of Selected Presentations From the American Association for the Study of Liver Diseases 2025 Liver Meeting November 7-11, 2025 • Washington, DC Two-Year Time […]
Highlights in Primary Biliary Cholangitis From the AASLD 2025 Liver Meeting
A Review of Selected Presentations From the American Association for the Study of Liver Diseases 2025 Liver Meeting November 7-11, 2025 • Washington, DC Seladelpar […]
Highlights in MASH From the American College of Gastroenterology 2025 Annual Scientific Meeting
A Review of Selected Presentations From the ACG 2025 Annual Scientific Meeting October 24-29, 2025 • Phoenix, Arizona Treatment With Resmetirom for Up to 2 Years […]